Filter by:

www.nba.gov.au

/var/www/disclogs/web/web/showDomain.php (line 14)
  • reset($query->fetchAll(PDO::FETCH_ASSOC))
    9
    array
    • domain_name
      www.nba.gov.au
      14
      string
    • second_level_domain_name
      nba.gov.au
      10
      string
    • whois
      null
      null
    • dns
      {"CNAME": ["nba.gov.au."]}
      stringjsonobject
    • ip_whois
      null
      null
    • active
      true
      boolean
    • data_created_at
      2018-03-30 04:13:09.790107+00
      -7m 4w
      stringdatetime
    • data_updated_at
      2018-04-02 05:31:40.390701+00
      -7m 4w
      stringdatetime
    • https
      {"ocsp_response": {"version": "1", "responses": [{"certID": {"serialNumber": "53AD8A8AC656C0840D990C661D3E9B48", "hashAlgorithm": "sha1", "issuerKeyHash": "F07051DAD32A914F5277D78677740FCE711A6C22", "issuerNameHash": "5FDE1FB98448CCFDD9C8895B6DD19FEDA6D3FB11"}, "certStatus": "good", "nextUpdate": "Apr 4 21:56:14 2018 GMT", "thisUpdate": "Mar 28 21:56:14 2018 GMT"}], "producedAt": "Mar 28 21:56:14 2018 GMT", "responderID": "34EC26C9DA4FE234A9FB206C871D39E63DDF9A9D", "responseType": "Basic OCSP Response", "responseStatus": "successful"}, "certificate_chain": [{"issuer": {"commonName": "thawte EV SSL CA - G3", "countryName": "US", "organizationName": "thawte, Inc."}, "subject": {"commonName": "www.blood.gov.au", "countryName": "AU", "localityName": "Lyneham", "serialNumber": "Government Entity", "businessCategory": "Government Entity", "organizationName": "National Blood Authority", "stateOrProvinceName": "Australian Capital Territory", "jurisdictionCountryName": "AU"}, "keyUsage": "<KeyUsage(digital_signature=True, content_commitment=False, key_encipherment=True, data_encipherment=False, key_agreement=False, key_cert_sign=False, crl_sign=False, encipher_only=None, decipher_only=None)>", "subjectAltName": ["www.nba.gov.au", "nba.gov.au", "blood.gov.au", "www.blood.gov.au"], "not_valid_after": "2019-10-11T23:59:59", "basicConstraints": "<BasicConstraints(ca=False, path_length=None)>", "extendedKeyUsage": "<ExtendedKeyUsage([<ObjectIdentifier(oid=1.3.6.1.5.5.7.3.1, name=serverAuth)>, <ObjectIdentifier(oid=1.3.6.1.5.5.7.3.2, name=clientAuth)>])>", "not_valid_before": "2017-10-11T00:00:00", "authorityInfoAccess": "<AuthorityInformationAccess([<AccessDescription(access_method=<ObjectIdentifier(oid=1.3.6.1.5.5.7.48.1, name=OCSP)>, access_location=<UniformResourceIdentifier(value='http://ti.symcd.com')>)>, <AccessDescription(access_method=<ObjectIdentifier(oid=1.3.6.1.5.5.7.48.2, name=caIssuers)>, access_location=<UniformResourceIdentifier(value='http://ti.symcb.com/ti.crt')>)>])>", "certificatePolicies": "<CertificatePolicies([<PolicyInformation(policy_identifier=<ObjectIdentifier(oid=2.16.840.1.113733.1.7.48.1, name=Unknown OID)>, policy_qualifiers=['https://www.thawte.com/cps', <UserNotice(notice_reference=None, explicit_text='https://www.thawte.com/repository')>])>, <PolicyInformation(policy_identifier=<ObjectIdentifier(oid=2.23.140.1.1, name=Unknown OID)>, policy_qualifiers=None)>])>", "cRLDistributionPoints": "<CRLDistributionPoints([<DistributionPoint(full_name=[<UniformResourceIdentifier(value='http://ti.symcb.com/ti.crl')>], relative_name=None, reasons=None, crl_issuer=None)>])>", "authorityKeyIdentifier": "<AuthorityKeyIdentifier(key_identifier=b'\\xf0pQ\\xda\\xd3*\\x91ORw\\xd7\\x86wt\\x0f\\xceq\\x1al\"', authority_cert_issuer=None, authority_cert_serial_number=None)>", "signature_hash_algorithm": "sha256", "PrecertificateSignedCertificateTimestamps": "<PrecertificateSignedCertificateTimestamps([<cryptography.hazmat.backends.openssl.x509._SignedCertificateTimestamp object at 0x7f332152d940>, <cryptography.hazmat.backends.openssl.x509._SignedCertificateTimestamp object at 0x7f332152d438>, <cryptography.hazmat.backends.openssl.x509._SignedCertificateTimestamp object at 0x7f332152d3c8>])>"}, {"issuer": {"commonName": "thawte Primary Root CA", "countryName": "US", "organizationName": "thawte, Inc.", "organizationalUnitName": "(c) 2006 thawte, Inc. - For authorized use only"}, "subject": {"commonName": "thawte EV SSL CA - G3", "countryName": "US", "organizationName": "thawte, Inc."}, "keyUsage": "<KeyUsage(digital_signature=False, content_commitment=False, key_encipherment=False, data_encipherment=False, key_agreement=False, key_cert_sign=True, crl_sign=True, encipher_only=None, decipher_only=None)>", "subjectAltName": ["<Name([<NameAttribute(oid=<ObjectIdentifier(oid=2.5.4.3, name=commonName)>, value='SymantecPKI-1-536')>])>"], "not_valid_after": "2023-10-30T23:59:59", "basicConstraints": "<BasicConstraints(ca=True, path_length=0)>", "not_valid_before": "2013-10-31T00:00:00", "authorityInfoAccess": "<AuthorityInformationAccess([<AccessDescription(access_method=<ObjectIdentifier(oid=1.3.6.1.5.5.7.48.1, name=OCSP)>, access_location=<UniformResourceIdentifier(value='http://t2.symcb.com')>)>])>", "certificatePolicies": "<CertificatePolicies([<PolicyInformation(policy_identifier=<ObjectIdentifier(oid=2.5.29.32.0, name=Unknown OID)>, policy_qualifiers=['https://www.thawte.com/cps'])>])>", "subjectKeyIdentifier": "<SubjectKeyIdentifier(digest=b'\\xf0pQ\\xda\\xd3*\\x91ORw\\xd7\\x86wt\\x0f\\xceq\\x1al\"')>", "cRLDistributionPoints": "<CRLDistributionPoints([<DistributionPoint(full_name=[<UniformResourceIdentifier(value='http://t1.symcb.com/ThawtePCA.crl')>], relative_name=None, reasons=None, crl_issuer=None)>])>", "authorityKeyIdentifier": "<AuthorityKeyIdentifier(key_identifier=b'{[E\\xcf\\xaf\\xce\\xcbz\\xfd1\\x92\\x1aj\\xb6\\xf3F\\xebWHP', authority_cert_issuer=None, authority_cert_serial_number=None)>", "signature_hash_algorithm": "sha256"}], "SSLV2 Cipher Suites": [], "SSLV3 Cipher Suites": [], "TLSV1 Cipher Suites": ["TLS_ECDHE_RSA_WITH_AES_256_CBC_SHA", "TLS_RSA_WITH_AES_256_CBC_SHA", "TLS_ECDHE_RSA_WITH_AES_128_CBC_SHA", "TLS_RSA_WITH_AES_128_CBC_SHA", "TLS_RSA_WITH_RC4_128_SHA", "TLS_RSA_WITH_RC4_128_MD5", "TLS_RSA_WITH_3DES_EDE_CBC_SHA"], "ocsp_response_status": 0, "TLSV1_1 Cipher Suites": [], "TLSV1_2 Cipher Suites": ["TLS_RSA_WITH_AES_256_CBC_SHA", "TLS_ECDHE_RSA_WITH_AES_256_CBC_SHA", "TLS_RSA_WITH_AES_256_CBC_SHA256", "TLS_RSA_WITH_RC4_128_MD5", "TLS_ECDHE_RSA_WITH_AES_128_CBC_SHA", "TLS_RSA_WITH_AES_128_CBC_SHA256", "TLS_ECDHE_RSA_WITH_AES_128_CBC_SHA256", "TLS_RSA_WITH_RC4_128_SHA", "TLS_RSA_WITH_AES_128_CBC_SHA", "TLS_RSA_WITH_3DES_EDE_CBC_SHA"], "TLSV1_3 Cipher Suites": [], "is_leaf_certificate_ev": true, "is_ocsp_response_trusted": true, "symantec_distrust_timeline": "SEPTEMBER_2018", "tls_server_name_indication": "www.nba.gov.au", "certificate_matches_hostname": true, "has_sha1_in_certificate_chain": false, "highest_ssl_version_supported": "TLSV1_2", "certificate_included_scts_count": 3, "has_anchor_in_certificate_chain": false, "openssl_cipher_string_supported": "AES128-SHA256", "is_certificate_chain_order_valid": true, "certificate_has_must_staple_extension": false}
      stringjsonobject
      • ocsp_response_status
        0
        integer
      • is_leaf_certificate_ev
        true
        boolean
      • is_ocsp_response_trusted
        true
        boolean
      • symantec_distrust_timeline
        SEPTEMBER_2018
        14
        string
      • tls_server_name_indication
        www.nba.gov.au
        14
        string
      • certificate_matches_hostname
        true
        boolean
      • has_sha1_in_certificate_chain
        false
        boolean
      • highest_ssl_version_supported
        TLSV1_2
        7
        string
      • certificate_included_scts_count
        3
        integer
      • has_anchor_in_certificate_chain
        false
        boolean
      • openssl_cipher_string_supported
        AES128-SHA256
        13
        string
      • is_certificate_chain_order_valid
        true
        boolean
      • certificate_has_must_staple_extension
        false
        boolean
titlepathsize_bytesword_countload_time
National Blood Authority | National Blood Authority / 73340 1015
10 Tips to Help Manage your Blood Product Inventory | National Blood Authority /10-tips-help-manage-your-blood-product-inventory 67823 1662 1.626463363
2016: Closed Public Consultations | National Blood Authority /2016-closed-public-consultations 65779 1185 1.374234101
2017 Closed Public Consultations | National Blood Authority /2017-closed-public-consultations 74842 2642 0.894159623
Australian Bleeding Disorders Registry (ABDR) | National Blood Authority /abdr 74945 1683 1.542769958
Overview: About Blood | National Blood Authority /about-blood 61172 1190 0.740643308
Overview and Role of the NBA | National Blood Authority /about-nba 71981 1982 1.595431432
Accessibility | National Blood Authority /accessibility 59408 1293 1.322839493
6. BloodMove Achievements Since the 2013 Case Study | National Blood Authority /Achievements 68917 1440 1.477162239
Recognising, Managing and Reporting Adverse Events for Blood Products | National Blood Authority /adverse-events 63676 1300 1.639911814
4. Age of Blood | National Blood Authority /age-of-blood 67705 1317 1.39202804
1. Aims | National Blood Authority /aims 68432 1280 1.217244306
Anti-D | National Blood Authority /anti-d 61303 1127 0.676910104
Australian Health Provider Blood and Blood Products Charter | National Blood Authority /australian-health-provider-blood-and-blood-products-charter 69185 1375 1.650692912
Barcode Specifications | National Blood Authority /barcoding 71081 1849 0.821587248
Best Practice - In this Section | National Blood Authority /best-practice 59435 878 1.33096736
BloodSTAR | National Blood Authority /best-practice/immunoglobulin-products/bloodstar 68184 1247 1.674768657
BloodSTAR Privacy Controls | National Blood Authority /best-practice/immunoglobulin-products/bloodstar-privacy-controls 64934 1170 1.316008495
Big Red | National Blood Authority /big-red 60355 947 1.43751646
Bleeding Disorders | National Blood Authority /bleeding-disorders 67900 1534 1.630393153
Blood Measures and Data Linkage | National Blood Authority /blood-measures-and-data-linkage 61659 1113 1.891192626
4. BloodMove features and strengths | National Blood Authority /bloodMove-features-strengths 77273 2167 2.810456
BloodMove Platelets - a successful system to significantly reduce platelet wastage | National Blood Authority /bloodmove-platelets 69577 1414 1.527310061
BloodMove Project Case Study | National Blood Authority /bloodmove-project-case-study 75701 1670 1.678397249
BloodNet | National Blood Authority /bloodnet 64156 1224 1.536694955
Certified Interfaces | National Blood Authority /bloodnet/certified-interfaces 64929 1118 1.413198355
BloodNet Laboratory Information System (LIS) Interfaces | National Blood Authority /bloodnet/lis-interfaces 70936 1368 1.664266211
BloodNet Milestone at the Fiona Stanley Hospital, WA | National Blood Authority /bloodnet-milestone-fiona-stanley-hospital-wa 60064 1115 1.296177302
BloodNet News | National Blood Authority /bloodnet-news 63014 960 1.297968281
BloodNet Specifications for Interfacing | National Blood Authority /bloodnet-specifications-interfacing 64287 1038 1.46230888
BloodNet Support Materials | National Blood Authority /bloodnet-support-materials 76140 1179 0.856246688
BloodPortal | National Blood Authority /bloodportal 62197 1043 1.523992071
Where can I find more information? | National Blood Authority /blood-service-implementing-isbt-128-labelling-june-2018 58002 823 1.622882869
BloodSTAR | National Blood Authority /bloodstar 67696 1178 0.825740986
BloodSTAR calculator for adjusting Ig dose for ideal body weight | National Blood Authority /bloodstar-calculator-adjusting-ig-dose-ideal-body-weight 64939 1320 1.114848109
BloodSTAR News April 2018 | National Blood Authority /bloodstar-news-april-2018 78416 2724 1.464288372
BloodSTAR News October 2017 | National Blood Authority /bloodstar-news-october-2017 73668 1902 1.652850919
BloodSTAR Privacy Controls | National Blood Authority /bloodstar-privacy-controls 64595 1101 1.555628217
BloodSTAR Support Materials | National Blood Authority /bloodstar-support-materials 65724 1011 1.250340736
Overview: Blood Systems | National Blood Authority /blood-systems 69937 1529 1.592332012
Burnside War Memorial Hospital Case Study | National Blood Authority /burnside-hospital-case-study 72142 1578 1.603508744
Case Studies | National Blood Authority /case-studies 73549 2231 1.530431692
Changes to National Product List | National Blood Authority /changes-national-product-list 60890 1036 1.382261098
National Blood Authority Customer Service Charter | National Blood Authority /charter 61684 1446 1.19346954
Closed Public Consultations | National Blood Authority /closed-public-consultations 63033 1102 1.396837901
2013: Closed Public Consultations | National Blood Authority /closed-public-consultations-2013 64087 1368 1.551608018
2014: Closed Public Consultations | National Blood Authority /closed-public-consultations-2014 66491 1661 1.649641945
2015: Closed Public Consultations | National Blood Authority /closed-public-consultations-2015 64041 1318 1.365430492
Committees and Working Groups | National Blood Authority /committees-and-working-groups 58382 922 1.448266752
Contact Us | National Blood Authority /contact-us 58438 907 0.698737013
Contracts with Suppliers | National Blood Authority /contracts-suppliers 66931 1509 1.089498698
Copyright | National Blood Authority /copyright 57759 1008 1.399795451
Creating an authorisation request | National Blood Authority /creating-authorisation-request 65206 971 1.709462043
Current Vacancies | National Blood Authority /current-vacancies 56587 844 1.483649074
Data Analysis and Reporting | National Blood Authority /data-analysis-reporting 76501 1398 1.629349545
Data Governance | National Blood Authority /data-governance 64886 1367 1.667754938
Overview: Data & Research | National Blood Authority /data-research 61969 1106 1.634366099
Disclaimer | National Blood Authority /disclaimer 59281 1336 1.523948433
Dispenser | National Blood Authority /dispenser 70681 937 1.194758217
Download PBM Guidelines: Module 6 - Neonatal and Paediatrics now | National Blood Authority /download-pbm-guidelines-module-6-neonatal-and-paediatrics-now 57885 801 1.559227275
Education and Training | National Blood Authority /education-and-training 69325 1693 1.607858507
Eligibility Requirements for Working at the National Blood Authority | National Blood Authority /eligibility-requirements-working-national-blood-authority 62839 1457 1.113160587
Working at the National Blood Authority | National Blood Authority /employment 61479 1068 0.902040268
Benefits of Working at the National Blood Authority | National Blood Authority /employment-benefits 63962 1514 1.673117672
Overview: Ensuring Supply | National Blood Authority /ensuring-supply 61752 1169 1.424250263
Facility Administrator | National Blood Authority /facility-administrator 67266 1006 1.349969833
Facility Certification Process | National Blood Authority /facility-certification-process 74392 2117 1.579624574
Fit for Surgery | Fit for Life | National Blood Authority /fit-surgery-fit-life 57314 806 1.432001383
Freedom of Information | National Blood Authority /freedom-information 66242 2063 1.138057879
Fresh Blood Product Procurement | National Blood Authority /fresh-blood-procurement 67996 1429 1.56854887
Fresh Blood Products | National Blood Authority /fresh-blood-products 63740 1391 0.846137303
Fresh Blood Products | National Blood Authority /fresh-blood-products-0 60857 1008 1.499940895
Further Updates to Supply Arrangements for Domestic Intravenous Immunoglobulin | National Blood Authority /further-updates-supply-arrangements-domestic-intravenous-immunoglobulin 57309 855 1.389063537
5. The future | National Blood Authority /future 67478 1183 1.451002016
Future Initiatives | National Blood Authority /future-initiatives 66856 1216 0.738349144
Governance Arrangements and Key Stakeholders | National Blood Authority /governance-arrangements 65115 1604 1.593171151
Governmental Compliance | National Blood Authority /governmental-compliance 63436 1310 1.058144998
Guidelines for the management of haemophilia in Australia | National Blood Authority /haemophilia-guidelines 63795 1075 0.698537403
Haemovigilance Reporting | National Blood Authority /haemovigilance-reporting 78860 2364 1.476830029
For Health Professionals | National Blood Authority /health-professionals 61252 1295 1.563462315
How to Apply for a Position at the National Blood Authority | National Blood Authority /how-apply-position-national-blood-authority 61640 1270 1.050620836
Hunter Area Pathology Service Case Study | National Blood Authority /hunter-area-pathology-service-case-study 69104 1417 1.578898035
National Immunoglobulin Governance Committees | National Blood Authority /Ig-committees 73602 1669 1.648909009
Immunoglobulin authorisation request forms | National Blood Authority /Ig-forms 70228 1543 0.922171723
Immunoglobulin Products | National Blood Authority /Ig-governance 64456 1131 1.053188359
National Immunoglobulin Governance Program | National Blood Authority /Ig-program 70455 1666 1.564760722
Ig Governance Criteria and Progress Updates | National Blood Authority /Ig-program-updates 69958 1867 1.766565046
3. Implementation and hub-spoke arrangements | National Blood Authority /Implementation 69527 1376 0.815729907
Implementation | National Blood Authority /implementation-0 73588 2045 1.691713084
Implementing the ELP Protocol | National Blood Authority /implementing-elp-protocol 71270 1857 1.511899822
Implementing the PBM Guidelines | National Blood Authority /implementing-pbm 89094 2765 1.701347495
Imported Products | National Blood Authority /imported-products 63581 1200 1.261991236
Improved outcomes | National Blood Authority /improved-outcomes 70749 1766 1.700827876
Access to Intravenous Immunoglobulin (IVIg) | National Blood Authority /Intravenous-Ig 73511 2039 1.60142655
Introduction, Background and Aim | National Blood Authority /introduction-background-and-aim 66180 1120 1.419471138
Managing Blood Product Inventory | National Blood Authority /inventory-management 66871 1321 1.508654588
Managing Blood and Blood Product Inventory Guidelines for Australian Health Providers | National Blood Authority /inv-mgt-guideline 67365 1246 1.76744085
3. Involved Haematologists | National Blood Authority /involved-haematologists 67378 1232 1.527146512
Criteria for the Clinical Use of Intravenous Immunoglobulin in Australia | National Blood Authority /ivig-criteria 90357 3967 0.835270844
Intravenous Immunoglobulin (IVIg) Request Forms | National Blood Authority /ivig-request-forms 69864 1032
Jurisdictional Reporting | National Blood Authority /jurisdictional-reporting 61603 1033 1.331330036
The Laboratory Process | National Blood Authority /laboratory-process 66773 1258 1.443243141
Liverpool Hospital RFID Case Study | National Blood Authority /liverpool-hospital-rfid-case-study 75747 2353 0.914990816
Managing blood at Burnside Hospital? | National Blood Authority /managing-blood-burnside-hospital 67719 1259 1.554859043
For Media | National Blood Authority /media 63917 1058
Prescriber / Nurse Practitioner (Medical Officer) | National Blood Authority /medical-officer 76625 1292 1.514712105
Meeting Standard 7 | National Blood Authority /meeting-standard-7 68577 1377 1.440661617
Module 1: Managing Blood and Blood Product Transfers | National Blood Authority /module-1-managing-blood-and-blood-product-transfers 67759 1168 1.419873165
Module 2: Ig Inventory Management Guidelines | National Blood Authority /module-2-ig-inventory-management-guidelines 64231 1003 1.209620114
Monitoring International Trends for the Blood Sector | National Blood Authority /monitoring-international-trends-blood-sector 76254 1405 1.525713739
MyABDR | National Blood Authority /myabdr 68630 1264 1.557357923
National Policy: Access to Government Funded Immunoglobulin Products in Australia - Second Edition Now Available | National Blood Authority /national-policy-access-government-funded-immunoglobulin-products-australia-second-edition-now 58955 852 1.47609235
National Policy: Access to Government Funded Immunoglobulin Products in Australia | National Blood Authority /national-policy-to-ig 67844 1273 1.507389174
What Blood Products are Supplied - National Product List | National Blood Authority /national-product-list 81857 1947 0.985201002
National Standard for Blood and Blood Products Safety and Quality | National Blood Authority /national-standard 65254 1270 1.627642719
National Blood Supply Contingency Plan | National Blood Authority /nbscp 66935 1510 1.613181464
Access to Normal Human Immunoglobulin (NHIg) | National Blood Authority /NHIg 68394 1449 0.939605394
National Immunohaematology Continuing Education (NICE) | National Blood Authority /nice 63943 1333 1.608509526
National Inventory Management Framework (NIMF) | National Blood Authority /nimf 75251 1725 1.556359406
National Managed Fund (NMF) | National Blood Authority /nmf 60984 1003 1.444994941
Nurse/ Midwife | National Blood Authority /nurse-midwife 72129 1207 1.66782273
Blood Operations Centre (BOC) | National Blood Authority /ops-centre 60935 1016 1.21418655
Out Now | National Blood Authority /out-now 57175 793 1.506108048
Overview: Publications & Tools | National Blood Authority /overview-publications-tools 60178 1019 1.4958034
Pathology Queensland Case Study | National Blood Authority /pathology-queensland-case-study 69308 1507 1.585423352
Patient Blood Management (PBM) | National Blood Authority /patient-blood-management-pbm 69377 1362 0.860005487
Patient factsheets and resources | National Blood Authority /patient-factsheets-and-resources 67446 1152 1.402207239
For Patients | National Blood Authority /patients 61313 1063 1.504416079
Patient Blood Management Guidelines | National Blood Authority /pbm-guidelines 69445 1433 0.871888936
Patient Blood Management Guidelines Progress Update : January 2018 | National Blood Authority /pbm-guidelines-updates 70040 1658 1.635960266
Patient Blood Management Guidelines: Launches | National Blood Authority /pbm-launch 73060 1336 1.461039436
Patient Blood Management Guidelines: Module 1 Critical Bleeding/Massive Transfusion | National Blood Authority /pbm-module-1 69617 1437 1.474215755
Patient Blood Management Guidelines: Module 2 Perioperative | National Blood Authority /pbm-module-2 70482 1457 1.718824331
Patient Blood Management Guidelines: Module 3 Medical | National Blood Authority /pbm-module-3 68760 1380 1.632349249
Patient Blood Management Guidelines: Module 4 Critical Care | National Blood Authority /pbm-module-4 69127 1399 1.471396558
Patient Blood Management Guidelines: Module 5 Obstetrics and Maternity | National Blood Authority /pbm-module-5 68874 1412 1.446390506
Patient Blood Management Guidelines: Module 6 Neonatal and Paediatrics | National Blood Authority /pbm-module-6 71105 1481 1.712395354
Plasma and Recombinant Product Procurement | National Blood Authority /plasma-and-recombinant-product-procurement 73833 1954 0.840477078
Plasma and Recombinant Products | National Blood Authority /plasma-and-recombinant-products 70750 2380 1.513970389
Platelets | National Blood Authority /platelets 62327 1013 1.487917147
Point of Care Coagulation Testing Case Study | National Blood Authority /point-care-coagulation-testing-case-study-prince-charles-hospital-brisbane 66363 1130 0.858296936
Post Implementation | National Blood Authority /post-implementation 70240 1799 1.532554853
Preoperative Anaemia Identification, Assessment and Management Case Study | National Blood Authority /preoperative-anaemia-identification-assessment-and-management-case-study 65780 1089 0.808318632
Privacy | National Blood Authority /privacy 73621 2845 1.630658676
Privacy of patient information in ABDR and MyABDR | National Blood Authority /privacy-info-abdr-myabdr 76373 1550 1.577463554
Procurement and Tenders | National Blood Authority /procurement 64003 1360 1.09611705
Publication Order Form | National Blood Authority /publication-order-form 76722 1089 1.817363317
Public Consultation | National Blood Authority /public-consultation 58770 858 1.417147187
Public Interest Disclosure | National Blood Authority /public-interest-disclosure 66043 1835 1.634812307
The Royal Children's Hospital Melbourne Extended Life Plasma Protocol Case Study | National Blood Authority /rch-elp-case-study 70184 1568 1.611700944
Red Cell Diagnostic Product Procurement | National Blood Authority /red-cell-diagnostic-reagents-product-procurement 66343 1185 0.679414129
Red Cell Usage | National Blood Authority /red-cell-usage 63148 1193 0.725568958
Redcliffe | National Blood Authority /redcliffe 69039 1604 1.726031061
Registering your facility for BloodSTAR* | National Blood Authority /registering-your-facility-bloodstar 107251 1801 1.767236721
Where do I Report Adverse Events | National Blood Authority /reporting-adverse-events 65503 1520 1.616611707
Research and Development | National Blood Authority /research-and-development 65888 1402 1.59925868
Search for Publications and Tools | National Blood Authority /resources 85973 1542 1.781986129
Results | National Blood Authority /results 68931 1416 0.930278227
Results of Round 1 National Blood Sector Research and Development Pilot | National Blood Authority /results-round-1 65703 1304 0.818461543
Results of Round 2 National Blood Sector Research and Development Pilot | National Blood Authority /results-round-2-national-blood-sector-research-and-development-pilot 64207 1120 0.682128312
Review and change management | National Blood Authority /review-and-change-management 70627 1706 1.483085373
Review of the Authorisation and Clinical Governance Framework for Intravenous Immunoglobulin (2012) | National Blood Authority /review-auth-clinical-gov 67015 1343 0.911568668
Risk Management | National Blood Authority /risk-management 61013 973 1.141504664
Royal Brisbane and Women’s Hospital | National Blood Authority /royal-brisbane-hospital 72559 1845 1.604682215
Safety of Blood Products | National Blood Authority /safety-blood-products 61943 1332 1.524860615
SAN Pathology Case Study | National Blood Authority /san-pathology-case-study 76706 2367 1.580659238
Access to Subcutaneous Immunoglobulin (SCIg) | National Blood Authority /SCIg 72756 1605 1.089774333
Subcutaneous Immunoglobulin (SCIg) Request Forms | National Blood Authority /scig-request-forms 67375 1041 0.670520044
Sector Performance Indicators | National Blood Authority /sector-performance-indicators 62205 1224 0.820210925
Small volume tubes at Flinders Medical Centre, SA | National Blood Authority /small-volume-tubes-flinders-medical-centre-sa 66084 1143 1.571325192
2. Speed of Release | National Blood Authority /Speed-of-Release 68284 1379 1.567998015
2. Staffing and governance | National Blood Authority /staffing-and-governance 67236 1204 1.142124645
Standard 7 and the Patient Blood Management (PBM) Guidelines | National Blood Authority /standard-7-and-patient-blood-management-pbm-guidelines 62625 1002 1.439549527
Standard 7 Review | National Blood Authority /standard-7-review 62512 1155 1.906293164
National Stewardship Program | National Blood Authority /stewardship 62764 1163 1.484002316
Stop the Waste! | National Blood Authority /stopthewaste 63675 1035 1.426338835
1. Strong Inventory Management and Control | National Blood Authority /strong-inventory-management 74644 2056 1.612026554
Customer Feedback on Commercial Supply Contracts | National Blood Authority /supplier-feedback 64002 1292 1.433752262
Supply to Australians Overseas | National Blood Authority /supply-australians-overseas 66712 1471 1.468374292
Supply Planning and Management | National Blood Authority /supply-planning 65423 1582 1.523530471
Supply Risk Management Measures | National Blood Authority /supply-risk-management-measures 66982 1691 1.60289733
Temporary Employment Register | National Blood Authority /temporary-employment-register 61594 1216 0.819209386
Toowoomba | National Blood Authority /toowoomba 68671 1483 1.756439694
Townsville | National Blood Authority /townsville 71867 1798 1.605884235
Vendor Certification Process | National Blood Authority /vendor-certification-process 75478 2204 1.410131806
National Blood and Blood Product Wastage Reduction Strategy 2013-17 | National Blood Authority /wastage 69727 1732 1.623132988
Who are Burnside and BloodSafe? | National Blood Authority /who-are-burnside-and-bloodsafe 67658 1185 1.61992934
Who will access BloodSTAR? | National Blood Authority /who-will-access-bloodstar 63459 1134 1.4610187